|
-
andrepharma3
2025-3-14
-
92
0
|
|
-
andrepharma3
2025-3-14
-
111
0
|
|
-
andrepharma3
2025-3-14
-
95
0
|
|
-
andrepharma3
2025-3-14
-
103
0
|
|
-
andrepharma3
2025-3-14
-
104
0
|
|
-
andrepharma3
2025-3-14
-
89
0
|
|
-
andrepharma3
2025-3-14
-
91
0
|
|
-
andrepharma3
2025-3-14
-
109
0
|
|
-
andrepharma3
2025-3-14
-
92
0
|
|
-
andrepharma3
2025-3-14
-
99
0
|
|
-
andrepharma3
2025-3-14
-
102
0
|
|
-
andrepharma3
2025-3-14
-
121
0
|
|
-
andrepharma3
2025-3-14
-
91
0
|
|
-
andrepharma3
2025-3-14
-
90
0
|
|
-
andrepharma3
2025-3-14
-
99
0
|
|
-
andrepharma3
2025-3-14
-
90
0
|
|
-
andrepharma3
2025-3-14
-
103
0
|
|
-
jhonmiller
2025-3-13
-
92
0
|
|
-
jhonmiller
2025-3-12
-
96
0
|
|
-
globaltrust
2025-3-12
-
90
0
|